CCS Fundraising
CCS Fundraising is the leading strategic consulting and management firm directing major fundraising initiatives for nonprofits worldwide. Through its unique service model, CCS drives the growth of the world’s most prominent philanthropic organizations with mission-critical fundraising solutions and delivers a high return on investment. The Company offers the most comprehensive planning, implementation, and management services for large-scale transformational fundraising initiatives outside the scope of traditional annual giving campaigns, as well as essential integrated service, offerings in data analytics, technology assessments, and planned giving. https://www.ccsfundraising.com
NAPEC
NAPEC is a leading provider of construction and maintenance services to the utility and heavy industrial markets across North America. The Company builds and maintains utility electrical and natural gas transmission and distribution systems and related energy infrastructure including substations. NAPEC also installs generation and other heavy equipment for utilities, industrial plants, and petrochemical facilities. The Company’s construction services also include environmental, renewable, and civil construction and road matting services. https://riggsdistler.com NAPEC was acquired in August 2021 by Centuri Group, Inc., wholly-owned subsidiary of Southwest Gas Holdings, Inc. (NYSE: SWX).
TurnCare
TurnCare is an early commercial stage medical device company that has developed a unique, patented non-invasive technology that helps protect and manage high acuity patients. TurnCare’s Guardian System is being used in acute care to manage patients that are both difficult to turn and at high risk of pressure injuries. Examples include mechanically and non-mechanically ventilated sepsis, cardiogenic shock, trauma, and respiratory failure critical care patients. Clinicians are looking to the Company’s Guardian System for help to mobilize these patients faster, with fewer skin injuries and less clinical effort. https://www.turncare.com
absorbD3
absorbD3 is an early stage medical technology company that has patented and patent-pending technology capable of producing a transdermal patch that delivers approximately 1,200 IU’s of Vitamin D3 through the skin and into the bloodstream on a daily basis, avoiding the gastrointestinal tract.
The Company's delivery system allows the absorption of Vitamin D3 by individuals, known as chronic mal-absorbers, who cannot or have difficulty absorbing orally ingested Vitamin D supplements, including individuals with cystic fibrosis, bariatric surgery patients, osteoporosis patients, and various gastro-intestinal disorders. The Company believes that is no other product available on the market today that delivers Vitamin D3 transdermally.
absorbD3
absorbD3 is an early stage medical technology company that has patented and patent-pending technology capable of producing a transdermal patch that delivers approximately 1,200 IU’s of Vitamin D3 through the skin and into the bloodstream on a daily basis, avoiding the gastrointestinal tract.
The Company's delivery system allows the absorption of Vitamin D3 by individuals, known as chronic mal-absorbers, who cannot or have difficulty absorbing orally ingested Vitamin D supplements, including individuals with cystic fibrosis, bariatric surgery patients, osteoporosis patients, and various gastro-intestinal disorders. The Company believes that is no other product available on the market today that delivers Vitamin D3 transdermally.